Unequal group sizes in randomised trials: guarding against guessing. (Q52938271)

9 May 2018

title

Unequal group sizes in randomised trials: guarding against guessing. (English)

1 reference

9 May 2018

2

David A Grimes

1 reference

9 May 2018

Kenneth F Schulz

1

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 March 2002

1 reference

9 May 2018

published in

The Lancet

1 reference

9 May 2018

volume

359

1 reference

9 May 2018

page(s)

966-970

1 reference

9 May 2018

issue

9310

1 reference

9 May 2018

Statistical properties of randomization in clinical trials

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

Generation of allocation sequences in randomised trials: chance, not choice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

Subverting randomization in controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

Allocation concealment in randomised trials: defending against deciphering

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

Randomisation and baseline comparisons in clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

How well are randomized controlled trials reported in the dermatology literature?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

Properties of permuted-block randomization in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

Randomization in clinical trials: conclusions and recommendations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

Properties of simple randomization in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

Properties of the urn randomization in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

Detecting selection bias in randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908029-7

7 January 2021

10.1016/S0140-6736(02)08029-7

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

11918933

1 reference

9 May 2018